UMIN ID: UMIN000001798
Registered date:25/03/2009
Prevention of cartilage destruction in rheumatoid arthritis by etanercept (PRECEPT study)
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Rheumatoid arthritis |
| Date of first enrollment | 2008/07/01 |
| Target sample size | 100 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Injection of etanercept by 50 mg/week for one year Injection of etanercept by 25 mg/week for one year |
Outcome(s)
| Primary Outcome | Total Sharp score (erosion and joint space narrowing) |
|---|---|
| Secondary Outcome | DAS28 |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Cases who have Joint destruction on hand and foot, in whom we can't measure modified Sharp score. Except Eetanercept dose, there is no restriction for other medicine use. |
Related Information
| Primary Sponsor | Team RA, Rheumatosurgery, Osaka City University Medical School |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Rheumatosurgery, Osaka City University Medical School |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Tatsuya Koike |
| Address | Abenoku Asahimachi 1-4-3, Osaka, 545-8585, Japan Japan |
| Telephone | 06-6645-3984 |
| tatsuya@med.osaka-cu.ac.jp | |
| Affiliation | Osaka City University Medical School Rheumatosurgery |
| scientific contact | |
| Name | Tatsuya Koike |
| Address | Abenoku Asahimachi 1-4-3, Osaka, 545-8585, Japan Japan |
| Telephone | 06-6645-3984 |
| Affiliation | Osaka City University Medical School Rheumatosurgery |